Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

3 results about "Stratum corneum" patented technology

The stratum corneum (Latin for 'horny layer') is the outermost layer of the epidermis. There has been a long-standing belief in dermatology that the stratum corneum consisted of dead cells (corneocytes), devoid of biological activity and function. The stratum corneum is now understood to be live tissue that performs protective and adaptive physiological functions including mechanical shear, impact resistance, water flux and hydration regulation, microbial proliferation and invasion regulation, initiation of inflammation through cytokine activation and dendritic cell activity, and selective permeability to exclude toxins, irritants, and allergens. This layer is composed of 15–20 layers of flattened cells with no nuclei and cell organelles. Their cytoplasm shows filamentous keratin. These corneocytes are embedded in a lipid matrix composed of ceramides, cholesterol, and fatty acids. Their properties depend on the component ratio of the three major components.

Analysis method for drugs in tissues

PendingCN114323894AAvoid Horizontal SlicingShorten experiment timeMaterial analysis using wave/particle radiationPreparing sample for investigationPharmaceutical drugStratum corneum
The invention provides a method for analyzing drugs in tissues. Quantitative analysis and detection are carried out on drug distribution conditions in in-vitro tissues by adopting a quantitative whole-body radioautography (QWBA) technology and a tissue embedding section. According to the invention, transverse slicing after longitudinal slicing is avoided, the experiment time is saved, the structure of each layer of the skin is accurately positioned, and the distribution condition of drugs in the cuticle, epidermal layer, dermis layer and subcutaneous tissue of the skin can be visually observed. And similar effects are achieved on other tissues.
Owner:XBL-CHINA INC

Microneedle for treating vitiligo as well as preparation method and application thereof

ActiveCN114796097AGood application effectReduce the number of dosesOrganic active ingredientsPeptide/protein ingredientsMelanophore-dispersing hormoneTofacitinib
The invention relates to a microneedle for treating leucoderma as well as a preparation method and application thereof, and relates to the field of medical biological materials. The microneedle comprises hydrogel, a water-soluble substrate material and an active pharmaceutical ingredient, the active pharmaceutical ingredient is selected from at least one of the following raw materials: melanotropin, tofacitinib, tacrolimus, pimerolimus or ruxolitinib. According to the microneedle, hydrogel with high mechanical strength is adopted, the microneedle can pierce the cuticle, the hydrogel is insoluble in water, the prepared microneedle does not need a large amount of organic solvent, after the microneedle pierces the cuticle, the medicine for treating leucoderma is directly delivered to the epidermal layer and the corium layer through the diffusion effect, and the medicine application effect is enhanced; meanwhile, the substrate of the microneedle is made of a water-soluble substrate material, after the skin is punctured by the microneedle, water is absorbed, the tip of the microneedle and the substrate of the microneedle are automatically separated, and the tip which is insoluble in water is remained in the skin, so that active pharmaceutical ingredients attached to the microneedle are released in a long-acting manner, and the administration frequency is reduced.
Owner:广州市皮肤病防治所
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products